Functional abnormality of proalbumin Christchurch.
Proalbumin Christchurch is a varient of human albumin in which the C-terminal basic residue of the propeptide has undergone a mutation to glutamine. In this investigation spectral and equilibrium dialysis studies have shown that the variant lacks the high affinity copper binding site of normal albumin. A simple electrophoretic procedure is described using 63Ni(II), which allow discrimination of proalbumins from other variants of albumin. The finding that Proalbumin Christchurch is readily cleaved in vitro by trypsin but is secreted uncleaved in vivo is evidence that propeptide cleavage is due to specific proteolysis with paired basic residues being a pre-requisite.
D000595:Amino Acid Sequence; D001665:Binding Sites; D003300:Copper / Q000378:metabolism*; D006801:Humans; D009532:Nickel / Q000494:pharmacology; D011228:Prealbumin / Q000378:metabolism*; D012709:Serum Albumin / Q000378:metabolism*; D014357:Trypsin
D011228:Prealbumin; D012709:Serum Albumin; D003300:Copper; D009532:Nickel; D014357:Trypsin